Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pemphigus Foliaceus”

9 trials

Showing 9 of 9 results

Not applicableLooking for participantsNCT02753777
What this trial is testing

Autoimmune Blistering Diseases Study

Who this might be right for
Pemphigus VulgarisPemphigus FoliaceusBullous Pemphigoid
University of Pennsylvania 150
Not applicableAvailableNCT04776694
What this trial is testing

Compassionate Use or Expanded Access of Dupilumab

Who this might be right for
Type 2 Inflammatory Disorders
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT03075904
What this trial is testing

A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
PemphigusPemphigus VulgarisPemphigus Foliaceus
Alexion Pharmaceuticals, Inc. 8
Large-scale testing (Phase 3)Ended earlyNCT03762265
What this trial is testing

PRN1008 in Patients With Pemphigus

Who this might be right for
Pemphigus
Principia Biopharma, a Sanofi Company 131
Large-scale testing (Phase 3)Study completedNCT04598451
What this trial is testing

Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 222
Large-scale testing (Phase 3)Ended earlyNCT04598477
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 183
Testing effectiveness (Phase 2)Study completedNCT03334058
What this trial is testing

Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 34
Early research (Phase 1)Ended earlyNCT03239470
What this trial is testing

Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Who this might be right for
Pemphigus FoliaceusPemphigus Vulgaris
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableUnknownNCT04117529
What this trial is testing

Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
Assistance Publique - Hôpitaux de Paris 40

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation